- Home
- CYRX vs OABI Comparison
CYRX vs OABI Comparison
Compare CYRX & OABI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CYRX
- OABI
- Stock Information
- Founded
- CYRX 1999
- OABI 2012
- Country
- CYRX United States
- OABI United States
- Employees
- CYRX N/A
- OABI N/A
- Industry
- CYRX Biotechnology: Pharmaceutical Preparations
- OABI Biotechnology: Pharmaceutical Preparations
- Sector
- CYRX Health Care
- OABI Health Care
- Exchange
- CYRX Nasdaq
- OABI Nasdaq
- Market Cap
- CYRX 405.4M
- OABI 459.1M
- IPO Year
- CYRX N/A
- OABI N/A
- Fundamental
- Price
- CYRX $8.02
- OABI $4.53
- Analyst Decision
- CYRX Buy
- OABI Strong Buy
- Analyst Count
- CYRX 6
- OABI 4
- Target Price
- CYRX $12.83
- OABI $9.00
- AVG Volume (30 Days)
- CYRX 346.4K
- OABI 349.2K
- Earning Date
- CYRX 11-07-2024
- OABI 11-12-2024
- Dividend Yield
- CYRX N/A
- OABI N/A
- EPS Growth
- CYRX N/A
- OABI N/A
- EPS
- CYRX N/A
- OABI N/A
- Revenue
- CYRX $225,606,000.00
- OABI $21,714,000.00
- Revenue This Year
- CYRX $1.00
- OABI N/A
- Revenue Next Year
- CYRX $8.87
- OABI $71.78
- P/E Ratio
- CYRX N/A
- OABI N/A
- Revenue Growth
- CYRX N/A
- OABI N/A
- 52 Week Low
- CYRX $5.32
- OABI $3.56
- 52 Week High
- CYRX $20.11
- OABI $6.72
- Technical
- Relative Strength Index (RSI)
- CYRX 58.29
- OABI 73.77
- Support Level
- CYRX $6.62
- OABI $4.04
- Resistance Level
- CYRX $8.76
- OABI $4.87
- Average True Range (ATR)
- CYRX 0.47
- OABI 0.18
- MACD
- CYRX 0.17
- OABI 0.10
- Stochastic Oscillator
- CYRX 65.42
- OABI 86.09
About CYRX CryoPort Inc.
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.
About OABI OmniAb Inc.
OmniAb Inc offers therapeutic antibody discovery technologies. The company focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.